脑部放疗,上午比下午敏感许多!) s; u- k: S1 L& q$ r) D% z- `
8 u: W! Y' \3 C; L( J2 y2 o/ _
' C9 ?$ i1 `7 E4 i: iCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
4 c6 i+ X0 P1 f) d; I( KGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?9 Y, Y7 E. ~- N% h
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
7 _0 l$ _/ `1 h6 I$ j' MSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.7 K: h3 d' @8 e, y) I6 V$ v
7 O$ E- e" {+ \8 qAbstract6 q' U, `% ~5 p9 r- y* e. w9 ?
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.) G9 @8 m; r& a6 _$ z
7 P0 [! H2 }$ k. Y1 `: MMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.' c" y7 p6 M- O- v$ G6 h# c6 b
, }6 E8 E( o+ L4 c0 Y
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
% C0 ?# |* l8 f' k9 T7 `7 i' e# K( }) J& \
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
( S: q0 b- S* e K% [: }- P t- k# Q2 H, u. W( M
|